Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Shared Experiences or Solo Experiences? No Matter the Preference, a Quality Experience Should be the Outcome

Consumers often sacrifice experience quality for companionship, creating an unexpected challenge for brands designing immersive entertainment

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By Elizabeth Bland · Elizabeth BlandMount St. Joseph UniversityQuality ExperiencesShared Experiences
Share

Key takeaways

01

Consumers often sacrifice experience quality for companionship, creating an unexpected challenge for brands designing immersive entertainment

Recent research reveals consumers frequently prioritize shared experiences with loved ones over the quality of the experience, often leading to dissatisfaction. Notably, a study of reviews left on the interactive play Sleep No More found that despite its design for a solo experience, 25% of attendees who stayed with companions reported lower satisfaction, underscoring the challenges and opportunities for marketers to address this consumer tendency.

Despite its design for a solo experience, 25% of attendees who stayed with companions reported lower satisfaction, underscoring the challenges and opportunities for marketers to address this consumer tendency.

How can businesses restructure their offerings to balance consumers' preference for togetherness with the quality of experience? Can businesses develop tiered experiences that allow for shared and solo elements to satisfy varying consumer preferences? Elizabeth Bland, DBA, an Assistant Professor of Management at Mount St. Joseph University, suggests industries can tailor their services to cater to group and solo patrons.

"I would say from a management perspective, train your employees to create maybe like a scavenger hunt or a competition so that people that come together can do something where they have to go out on their own and find answers… to engage the customer more and to make them kind of force them into doing things alone,” Bland said.

Train your employees to create maybe like a scavenger hunt or a competition so that people that come together can do something where they have to go out on their own and find answers to engage the customer more and to make them kind of force them into doing things alone.
— Elizabeth Bland, DBA, Assistant Professor of Management at Mount St. Joseph University

Elizabeth Bland, DBA, is an Assistant Professor of Management at Mount St. Joseph University.

About the author

EB
Elizabeth Bland

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

EB
Elizabeth Bland

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512